RxDoctor Payments Data

Anita Kumar, MD

Internal Medicine · Virginia Beach, VANPI 1982745840

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 3 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Every reported general payment came from a single manufacturer, Irhythm Technologies, Inc.. That places this record below the midpoint for internal medicine clinicians in VA, where the typical reported total is $141.

$57in general payments, 2019–2025

Across 3 payments — averaging $19.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Irhythm Technologies, Inc.$57
$71,871in research payments, 2019–2025

Across 1 payment — averaging $71,871 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Bristol Myers Squibb$72K

What the payments were for

  • Food & beverage$57100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Irhythm Technologies, Inc.3$57

How this compares

$57 in reported general payments places this provider in the 35th percentile of 2,724 internal medicine providers in Virginia.

See all internal medicine providers in Virginia

Medicare billing

Part B allowed, 2024
$196,979
Medicare patients
357
Services billed
3,949

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban51$68,197
OzempicSemaglutide45$61,464
JanuviaSitagliptin Phosphate23$36,417
XareltoRivaroxaban19$17,957
JardianceEmpagliflozin12$16,204
Trelegy ElliptaFluticasone/Umeclidin/Vilanter17$15,417
Atorvastatin Calcium431$4,492
Lantus SolostarInsulin Glargine,hum.Rec.Anlog19$3,363
Levothyroxine Sodium265$3,044
Metoprolol Succinate146$2,365
Humulin 70/30 KwikpenInsulin Nph Hum/Reg Insulin Hm12$2,331
Albuterol Sulfate HfaAlbuterol Sulfate64$1,912
Lidocaine18$1,849
Losartan Potassium167$1,756
Diltiazem 24hr Er (Cd)Diltiazem Hcl58$1,553

Paid to pharmacies, not to this prescriber.

Other internal medicine in Virginia Beach

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →